Atea Pharmaceuticals, Inc.
AVIR • NASDAQ • Stock Fundamentals
Atea Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jean-Pierre Sommadossi, with a market cap of $362.5M.
Market Cap$362.5M
Employees74.0
CEOJean-Pierre Sommadossi
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Atea Pharmaceuticals, Inc. FAQ
Common questions about Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc. (AVIR) has a market capitalization of $362.5M and trades on NASDAQ.
Atea Pharmaceuticals, Inc. has approximately 74 employees.